Cellectis (CLLS) Short term Debt (2015 - 2026)
Cellectis (CLLS) posted quarterly Short term Debt of $8.9 million for Q1 2026, down 46.96% year-over-year from $16.8 million in Q1 2025, and down 14.88% quarter-over-quarter from $10.5 million in Q4 2025.
Analysis
Cellectis (CLLS) Short term Debt (2015 - 2026) Analysis & Trends
Cellectis' Short term Debt history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Short term Debt fell 46.96% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (down 46.96% YoY), while the FY2025 annual figure was $10.5 million, down 35.17% from the prior year.
- Short term Debt for Q1 2026 stood at $8.9 million, down from $10.5 million in the prior quarter.
- The five-year high for Short term Debt was $18.2 million in Q3 2025, with the low at $5.1 million in Q3 2023.
- The 5-year median for Short term Debt is $8.9 million (2026), against an average of $9.7 million.
- The sharpest annual moves came in 2023 and 2025: Short term Debt sank 58.85% in 2023, then soared 256.12% in 2025.
- Cellectis' Short term Debt stood at $5.1 million in 2022, then climbed by 3.95% to $5.3 million in 2023, then jumped by 205.05% to $16.1 million in 2024, then slumped by 35.17% to $10.5 million in 2025, then dropped by 14.88% to $8.9 million in 2026.
- Business Quant data shows CLLS's Short term Debt at $8.9 million in Q1 2026, $10.5 million in Q4 2025, and $18.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 Mn |
| Mar 31, 2026 | 8.90 Mn |
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 18.24 Mn |
| Jun 30, 2025 | 18.23 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 16.13 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 10.38 Mn |
| Jun 30, 2022 | 11.31 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Dec 31, 2019 | 1.07 Mn |